Oncolytics Biotech

$3.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.36 (+9.91%) As of 5:21 PM UTC today

Why Robinhood?

You can buy or sell ONCY and other stocks, options, and ETFs commission-free!

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada. The listed name for ONCY is Oncolytics Biotech, Inc. Common Shares.

CEO
Matthew C. Coffey
Employees
23
Headquarters
Calgary, Alberta
Founded
1998
Market Cap
174.49M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.36M
High Today
$4.05
Low Today
$3.63
Open Price
$3.64
Volume
1.38M
52 Week High
$6.02
52 Week Low
$0.94

Collections

ONCY Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, After Hours

You May Also Like